Sun Pharma ends marginally lower despite research pact with Weizmann
Billionaire Dilip Sanghavi-led Sun Pharma has entered into a tripartite research and option agreement with Israel-based Weizmann Institute of Science and Spain’s Health Research Institute of Santiago de Compostela.